Portfolio news 0

Circassia Pharmaceuticals plc (LSE: CIR) will announce its preliminary results for the year ended 31 December 2018 on Wednesday 1 May 2019. 

A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am.  A webcast of the presentation will be available on the Company's website.

 

Contacts

Circassia	Tel: +44 (0) 1865 405 560
Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications
Peel Hunt (Nominated Adviser and Joint Broker)	Tel: +44 (0) 20 7418 8900
James Steel / Dr Christopher Golden
Numis Securities (Joint Broker)	Tel: +44 (0) 20 7260 1000
James Black / Freddie Barnfield
FTI Consulting	Tel: +44 (0) 20 3727 1000
Simon Conway / Ciara Martin